- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Canada OKs Cutera's Excel V laser system
Cutera has announced that Canadian regulatory agency Health Canada has approved the company’s Excel V laser for vascular, pigment and overall skin-rejuvenation treatments, Globe Newswire reports.
Brisbane, Calif. - Cutera has announced that Canadian regulatory agency Health Canada has approved the company’s Excel V laser for vascular, pigment and overall skin-rejuvenation treatments, Globe Newswire reports.
The Excel V system features a dual wavelength platform. One handpiece includes a 532 nm laser for superficial vessels and pigments, and a 1,064 nm Nd:YAG laser to treat leg veins, port wine stains and hemangiomas. The second handpiece, for facial rejuvenation, affords a collagen-producing solution for fine lines, uneven texture and premature aging.
The Excel V also features ergonomic handpieces, a solid-state design and a sapphire window with real-time calibration and spot size adjustment, enabling the precise targeting of lesions, the company states.
Go back to the Dermatology Times eNews newsletter.
